Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Press release cover image

Aug 12, 2026

Press release

Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process

Patent protects the precision of MRS data capture within the target disc — a critical step in the Nociscan workflowDesigned to reduce scan time, support faster technologist onboarding and deliver more reproducible results across imaging centersExtends Aclarion's IP protection to over 65 issued and pending patents worldwide, complementing its broader portfolio covering spectroscopy acquisition, data processing, biomarkers and analytics BROOMFIELD, Colo., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Aclario
A glass vial with a drug compound on a lab bench

Aug 12, 2026

Ohio State launches AI-enabled biotech initiative to speed drug discovery

The Ohio State University has unveiled Buckeye BioLaunch, an innovative initiative aimed at accelerating drug discovery through AI technology.This program integrates clinical and genomic data with academic research, leveraging resources from the Ohio State Wexner Medical Center and its Comprehensive Cancer Center, as well as the Colleges of Medicine and Pharmacy. The overarching goal is to establish a robust pipeline for therapeutic development, fostering economic growth and job creation in Cent
A jar of herbal medicine in a dimly lit lab setting

Aug 12, 2026

India to integrate AI into Ayush and more briefs

India is set to enhance its traditional medicine framework by integrating artificial intelligence (AI) through a collaboration between the Ministries of Electronics and Information Technology and Ayush.This partnership aims to promote AI research and application within the Ayush ecosystem, which encompasses traditional medicinal practices. The Ministry of Ayush will provide anonymized datasets, AI models, and toolkits to the AIKosh repository developed by the Ministry of Electronics and Informat
A minimalist representation of a health coach and patient in a digital healthcare setting.

Aug 12, 2026

Tāmaki Health extends health coaching with AI

Tāmaki Health is pioneering the integration of AI in New Zealand's primary healthcare by introducing a conversational AI-powered health coach across selected clinics.The AI Health Coach serves as a continuous digital resource, allowing patients to engage in health coaching discussions at any time, whether before, during, or after their appointments. By utilizing patient-provided information, the AI customizes evidence-based advice and action plans tailored to individual health goals and concerns
A minimalist representation of an X-ray film highlighting a bone structure in lime green against a dark background.

Aug 12, 2026

5 Companies Using AI to Transform Diagnostics and Medical Imaging

AI is revolutionizing diagnostics and medical imaging, enabling healthcare providers to enhance efficiency and accuracy in clinical decision-making.The integration of artificial intelligence in healthcare is transforming how diagnoses are made, particularly in medical imaging. AI technologies are being utilized to analyze various diagnostic data, including X-rays and CT scans, assisting professionals in identifying abnormalities and prioritizing urgent cases. This shift is crucial as healthcare
Samsung Galaxy Buds on a wooden table with a hearing test booklet

Aug 12, 2026

Samsung hearing aid features for its ear buds garner FDA clearance

Samsung Electronics has received FDA clearance for new software features that enable its Galaxy Buds to function as an over-the-counter (OTC) hearing aid, including a diagnostic hearing test capability.The new software, classified as a medical device, delivers medical-grade results, as noted in a recent press release. This development is particularly significant given the World Health Organization's projection that the number of individuals experiencing hearing loss globally will rise from 1.5 b
A minimalist illustration of a vaccine vial and virus silhouette on a solid background.

Aug 12, 2026

AI-engineered Vaccine Approach Could End Cycle of Variant Chasing

A novel vaccine technology developed by DIOSynVax, a spin-out from the University of Cambridge, aims to revolutionize vaccine development by targeting multiple viruses at various lifecycle stages. This approach, which integrates genomics, synthetic biology, and artificial intelligence, seeks to create broadly protective antigens that can be adapted for diverse delivery systems.The impetus for DIOSynVax's innovation stemmed from the Ebola outbreak of 2014-2016, which highlighted the need for vacc
Press release cover image

Aug 12, 2026

Press release

VB Spine Completes Transaction for CT-Fluoro Technology from Augmedics

CT-Fluoro technology will be integrated into VB Spine’s growing xvision platformNEW YORK--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), the largest privately held spine company, today announced it has completed its acquisition of the exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications and will immediately begin integrating the technology into the xvision Spine System® platform."We are pleased to complete this transaction and continue building on the momen
Press release cover image

Aug 12, 2026

Press release

Nucleai Advances AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration

Collaboration demonstrates how AI-powered Tissue Intelligence is transforming biomarker discovery, translational research, and precision oncology development.TEL AVIV, Israel--(BUSINESS WIRE)--Nucleai, a leader in AI-powered Tissue Intelligence, which integrates multimodal tissue image analysis with clinical data to deliver translational insights, today announced an ongoing translational research collaboration with Gilead Sciences supporting its global antibody-drug conjugate (ADC) clinical deve
Press release cover image

Aug 12, 2026

Press release

Leica Biosystems Enables Faster Cancer Diagnoses Through Multiple Digital Pathology FDA Clearances, Including Industry-First AI-Assisted Quality Control Software

Portfolio expansion marks new era for diagnosis delivery, translating digital pathology innovation to clinical impact by accelerating workflows and patient careVISTA, Calif., Aug. 11, 2026 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, today announced multiple U.S. Food and Drug Administration (FDA) 510(k) clearances that strengthen its connected clinical digital pathology portfolio, including the industry's first s
A complex reagent in a glass vial on a lab bench with shelves of equipment in the background.

Aug 12, 2026

Teknova: Build-Tek AI Configures Complex Custom Reagents In Minutes As Biotech Manufacturing Platform Expands

Teknova has introduced Build-Tek, an AI-driven custom product configurator that enables rapid creation of complex reagent requests, facilitating a faster transition from preclinical research to clinical manufacturing.This innovative platform builds on Teknova’s previous custom configurator launched in 2024 and aims to streamline the traditionally intricate custom manufacturing process. By automating product configuration, Build-Tek allows researchers to efficiently design products while ensuring
Press release cover image

Aug 11, 2026

Press release

PharmaTher Establishes PERSONALIZ3D(TM) to Commercialize a Personalized Medicine Platform Combining Telehealth and Pharmaceutical 3D Printing

Potential near-term commercialization through two synergistic business units: (i) a telehealth platform connecting patients with independent licensed healthcare providers and (ii) a North American network of pharmacy-based pharmaceutical 3D-printing systems for compounding medications, together forming a personalized medicine ecosystem Toronto, Ontario--(Newsfile Corp. - August 11, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) (the "Company" or "P